Tjalf Ziemssen

72PUBLICATIONS
372CO-AUTHORS
Toxicology (incl. clinical toxicology)Transport properties and non-equilibrium processesSexualitiesMedical infection agents (incl. prions)Neurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (72)

|Jul 16, 2026
The Art of Sequencing Disease-Modifying Therapies in Multiple Sclerosis.

|Jul 09, 2026
Challenges and future directions for multiple sclerosis after the 2024 McDonald diagnostic criteria.

|Jun 01, 2026
Sex-specific analysis of early disease course and treatment in a German multiple sclerosis cohort.

|May 14, 2026
A CSF disease-associated macrophage signature defines progressive multiple sclerosis.

|Apr 23, 2026
Emerging CSF and Serum Biomarkers in Multiple Sclerosis: Cytokines, MOG, GFAP, and Beyond.

|Mar 18, 2026
Treatment-free remission in MS: long-term disease control with cladribine tablets.

Heinz Wiendl, Ralf Gold, Refik Pul

Pageof 12

Frequent Collaborators

12 joint publications

Gerd Meyer Zu Horste

10 joint publications

Jan D Lünemann

8 joint publications

Luisa Klotz

8 joint publications

Michael Heming

Tjalf Ziemssen - Author Profile | JoVE Visualize